| Multiple | Now | Sector median | Where it sits |
|---|---|---|---|
| P/E | −9.9× | −1.7× | |
| Price / Book | 1.0× | 2.0× | |
| Price / Sales | 14.9× | 3.9× | |
| Price / Free cash flow | −0.4× | −1.6× | |
| EV / EBITDA | −0.2× | −1.2× | |
| Earnings yield | −10.1% | −14.4% | |
| Free cash flow yield | −226.3% | −9.9% |
| Company | Price | Change | Mkt cap (USD) | P/E | ROE | 1Y |
|---|---|---|---|---|---|---|
LLNYSE:LLYEli Lilly and Co · 🇺🇸 NYSE | $1,292.54 | +4.21% | $1.22T | 56.6× | 77.8% | +15.2% |
JNNYSE:JNJJohnson & Johnson · 🇺🇸 NYSE | $259.15 | +2.11% | $624.53B | 22.8× | 32.9% | +32.1% |
ABNYSE:ABBVAbbVie Inc · 🇺🇸 NYSE | $289.71 | +2.49% | $511.95B | 118.2× | −129.2% | +24.6% |
UNNYSE:UNHUnitedHealth Group Inc · 🇺🇸 NYSE | $421.85 | +3.68% | $378.65B | 30.3× | 12.8% | +14.1% |
MRNYSE:MRKMerck & Co Inc · 🇺🇸 NYSE | $147.97 | +3.02% | $365.07B | 19.4× | 34.7% | +71.2% |
NVNYSE:NVSNovartis AG · 🇺🇸 NYSE | $153.30 | +2.06% | $282.61B | 19.7× | 30.5% | +14.9% |
AZNYSE:AZNAstraZeneca PLC · 🇺🇸 NYSE | $168.61 | +2.84% | $261.5B | 24.8× | 21.1% | −2.4% |
TMNYSE:TMOThermo Fisher Scientific Inc · 🇺🇸 NYSE | $686.85 | +1.10% | $253.96B | 37.3× | 12.6% | +26.6% |
AMNAS:AMGNAmgen Inc · 🇺🇸 NAS | $434.57 | +2.27% | $234.94B | 29.8× | 89.1% | +43.7% |
GINAS:GILDGilead Sciences Inc · 🇺🇸 NAS | $155.27 | +1.44% | $192.53B | 22.3× | 37.5% | +29.9% |
